Table 1.
Clinical and demographic data of AKI cases and non-AKI controls of post-cardiac surgery patients
| Parameter | AKI | Non-AKI | p |
|---|---|---|---|
| Patients/samples (n/n) | 59/59 | 51/51 | |
| Age (years)† | 65 (45–77) | 60 (24–77) | 0.03 |
| Gender (female/male) | 13/46 | 16/35 | 0.29 |
| EuroSCORE II** (points)† | 6.82 (0.86–28.34) | 5.99 (0.67–21.93) | 0.89 |
| Body mass index† | 30.7 (19.9–47.3) | 30.8 (17.3–41.4) | 0.86 |
| S-creatinine at baseline (mg/dL)† | 1.1 (0.6–1.9) | 0.9 (0.6–1.3) | <0.001 |
| Estimated glomerular filtration rate at baseline (mL/h/1.73 m2)‡,† | 73 (37–110) | 92 (56–132) | <0.001 |
| Diabetes (%) | 29 | 18 | 0.19 |
| OP time (min)† | 214 (105–390) | 211 (109–651) | 0.6 |
| Time of cardiopulmonary bypass (min)† | 109 (48–243) | 103 (34–177) | 0.81 |
| Clamping time (min)† | 66 (17–184) | 67 (26–125) | 0.77 |
| Endpoints: | |||
| NOMI (%)ǁ | 29 | 2 | <0.001 |
| Death (%)ǁ | 17 | 0 | 0.002 |
| AKI staging (n): | |||
| 0 | 0 | 51 | |
| 1 | 25 | 0 | |
| 2 | 14 | 0 | |
| 3 | 20 (15 w/ hemodialysis) | 0 |
AKI acute kidney injury, NOMI nonocclusive mesenteric ischemia,
**Thoracic Surgeons Risk Score to predict mortality after thoracic surgery, for calculation see: http://www.euroscore.org/
‡According to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
†Given as mean (range)
ǁ7 % of AKI patients with composite endpoint